Low-Sodium Oxybate in the Treatment of Narcolepsy and Idiopathic Hypersomnia

Opinion
Video

An expert discusses the significance of low-sodium oxybate for patients with narcolepsy patients with and cardiovascular disease and compares the diagnostic criteria and clinical presentations of narcolepsy and idiopathic hypersomnia.

Video content above is prompted by the following:

  • What is the significance of low-sodium oxybate formulations for patients with narcolepsy who have comorbid cardiovascular disease (CVD)?
  • Low-sodium oxybate is also currently the only FDA-approved treatment for idiopathic hypersomnia (IH). How do the diagnostic criteria and clinical presentations of narcolepsy differ from those of IH?

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Recent Videos
2 experts are featured in this series.
1 expert is featured in this series.
1 expert in this video
1 expert in this video
1 expert in this video
2 experts are featured in this series.
1 expert is featured in this series.
1 expert in this video
1 expert in this video
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.